Sherwin-Williams Target price 2026 - Analyst rating & recommendation
Sherwin-Williams Classifications & Recommendation
Sherwin-Williams Price Target
| Target Price | $403.92 |
| Price | $344.10 |
| Potential | 17.38% |
| Number of Estimates | 26 |
| 26 Analysts have issued a price target Sherwin-Williams 2027 . The average Sherwin-Williams target price is $403.92. This is 17.38% higher than the current stock price. The highest price target is $441.00 28.16% , the lowest is $343.40 0.20% . | |
| A rating was issued by 34 analysts: 18 Analysts recommend Sherwin-Williams to buy, 16 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Sherwin-Williams stock has an average upside potential 2027 of 17.38% . Most analysts recommend the Sherwin-Williams stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
28 Analysts have issued a sales forecast Sherwin-Williams 2026 . The average Sherwin-Williams sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
27 Analysts have issued an Sherwin-Williams EBITDA forecast 2026. The average Sherwin-Williams EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
31 Sherwin-Williams Analysts have issued a net profit forecast 2026. The average Sherwin-Williams net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Sherwin-Williams...
Current Sherwin-Williams Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 29 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 29 2026 |
| Guggenheim |
Buy
➜
Buy
|
Unchanged | Oct 28 2026 |
| DA Davidson |
Buy
➜
Buy
|
Unchanged | Oct 28 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 28 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 28 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 28 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 29 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 29 2026 |
|
Unchanged
Guggenheim:
Buy
➜
Buy
|
Oct 28 2026 |
|
Unchanged
DA Davidson:
Buy
➜
Buy
|
Oct 28 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 28 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 28 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 28 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
